Nephrostomy Devices Market - By Product (Guidewires, Drainage Tubes, Nephrostomy Catheters, Sheath Dilators), By End-use (Hospitals, Clinics, Ambulatory Surgical Centers) & Global Forecast, 2023 – 2032

Nephrostomy Devices Market Size

Nephrostomy Devices Market size was valued at around USD 1.1 billion in 2022 and is anticipated to grow at a CAGR of over 8.3% between 2023 and 2032.This incremental growth rate is owing to increasing prevalence of kidney disorders coupled with rising demand for minimally invasive surgeries.
 

Technological advancements pertaining to nephrostomy devices in the diagnosis and treatment of several chronic ailments including bladder, ovarian, and prostate cancers is expected to augment the market growth in the forecasted timeframe. Rising healthcare spending for providing better healthcare infrastructure, increasing disposable income and consistently increasing geriatric population are some of the major factors responsible for increased adoption of nephrostomy devices across the world.
 

A nephrostomy device is a medical device used to drain urine from the kidney through a tube that is inserted through the skin and into the kidney. These devices are intended to remove an obstruction in the urinary tract, such as a kidney stone or tumor, that is preventing urine from flowing properly.
 

However, availability of substitute procedures for nephrostomy can act as a significant barriers and thereby impede the nephrostomy devices market growth in the coming years. There are several alternative procedures that may be used instead of a nephrostomy, depending on the specific medical condition and individual circumstances of the patient. This procedure is majorly used to treat kidney stones, tumors, or other obstructions in the urinary tract.
 

COVID-19 Impact

The recent outbreak of COVID-19 had negatively influenced the nephrostomy devices industry revenue surge, specifically during the first half of 2020. The coronavirus outbreak proliferated the disease burden and hampered several global businesses including the healthcare sector, during initial phase of 2020. These conditions negatively impacted the nephrostomy devices market growth. Due to the travel restrictions, the published data indicates that the management of urinary disorders & nephrostomy procedure were impacted by the pandemic unfavorably in the hospitals and primary care settings. Although later the market recovered, thereby mitigating the initial impact. Furthermore, as the number of COVID-19 infected patients decreased significantly and several healthcare facilities began delivering healthcare services, gradually returning the procedural volume to pre-pandemic levels.
 

Nephrostomy Devices Market Trends

Increasing prevalence of kidney disorders is expected to augment the demand of nephrostomy devices across the globe. Factors such as changes in diet and lifestyle, increased prevalence of obesity, and ageing population will fuel the market growth. Kidney disorders such as kidney stones, tumors, and infections can cause urinary tract obstructions that requires nephrostomy devices to drain urine from the kidney. For instance, according to the U.S. Department of Health and Human Services and National Cancer Institute, in 2023 report, estimated to witness around 82,290 new cases of bladder cancer in the U.S. These rising incidence rate of chronic ailments is expected to increase the product adoption rate in several countries globally. Therefore, the afore-mentioned statistics are expected to drive the adoption of nephrostomy devices.
 

Nephrostomy Devices Market Analysis

Based on product, the market is segmented as guidewires, drainage tubes, nephrostomy catheters, sheath dilators and others. The guidewires dominated the nephrostomy devices market in 2022 accounting for more than 32% of the total industry share. This high market share is owing to several benefits offered by guidewires in the management of kidney disorders. These devices guide the placement in the kidney and reduce the risk of complications such as bleeding or injury to surrounding organs. Additionally, these devices help reduce the trauma to surrounding tissues, minimize pain and discomfort and help in improving the safety of the procedure.
 

Based on end-use, the nephrostomy devices market is segmented as hospitals, clinics, ambulatory surgical centers and others. The hospital segment held the highest industry share in 2022 and is projected to grow at 8.2% CAGR from 2023-2032. This high market share is owing to the availability of advanced treatments for several kidney diseases and technologically advanced urinary catheters to assist a wide customer base. Enhanced operability and accessibility to comprehensive range of treatments incorporating nephrostomy procedures is expected to drive the market growth. Increasing admissions with chronic kidney disorders due to passive lifestyle and increasing instances of hospitalizations with a robust healthcare system is expected to boost the industry expansion. Thus, accessibility to better treatment & diagnosis coupled with the rising prevalence of these disorders will boost patient visits to hospitals.
 

U.S. nephrostomy devices market is predicted to reach around USD 863 million by 2032. This market share is attributable to numerous variables including the presence of key market players, an increase in the number of chronic diseases, and rising awareness regarding the benefits of pre nephrostomy devices for diagnosis and treatment of kidney ailments among others.
 

Nephrostomy Devices Market Share

Some of the major players operating in the nephrostomy devices market are:

• Angiodynamics
•  Argon Medical Devices Inc
•  B. Braun Melsungen AG
•  Becton
•  Dickinson and Company
•  Boston Scientific Corporation
•  Cardinal Health
•  Coloplast Group 
• Cook Medical
•  Envaste Ltd
•  Meditech
•  Devices Pvt Ltd
•  Olympus Corporation
•  ROCAMED
•  Teleflex Inc. and Uresil LLC.,

These leading market players are implementing advanced technologies to cater to the large unmet needs of the consumers. These players focus on strategic partnerships, new product launch & commercialization for market expansion. Furthermore, these players are heavily investing in research that allows them to introduce innovative products.
 

Nephrostomy Devices Industry in News:

• In August 2020, Argon Medical Devices, Inc. announced the launch of SKATER Mini-Loop Drainage Catheters for nephrostomy procedures in the U.S. and Europe. This device uses a 40% smaller loop to help secure the catheter and drain fluid from smaller cavities. This innovative product launch helped the company to increase their product portfolio and enhance their business revenue.
   
• In 2019, Argon Medical Devices, Inc., announced the acquisition of Mana-Tech, Ltd.  a distributor of medical devices including nephrostomy devices in the UK and Ireland. This acquisition helped the company to enhance their customer base and provide growth opportunity to expand our commercial reach throughout Europe.
   

Nephrostomy devices market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million & Units from 2018 to 2032, for the following segments:

Click here to Buy Section of this Report

By Product

• Guidewires
• Drainage Tubes
• Nephrostomy Catheters
• Sheath Dilators
• Others

By End-use

• Hospitals
• Clinics
• Ambulatory Surgical Centers
• Others  

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Poland
  • Sweden
  • The Netherlands
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Indonesia
  • Thailand
  • Philippines
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Chile
  • Peru
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Egypt
  • Turkey